Clinical Trial Update: A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

A randomized phase 2/3 trial comparing cabazitaxel, docetaxel, mitoxantrone, or satraplatin plus surgery for prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• DOCETAXEL (DOCETAXEL)
• Mitoxantrone (mitoxantrone)
• satraplatin (satraplatin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Prostate Cancer Patients | Phase 2, Phase 3 | Status: RECRUITING